In The Netherlands about 1650 women are treated for cervical cancer every year and 350 of them die of the disease (Central Bureau voor de Statistiek, 1984) . Carcinoma of the cervix is the second most frequent tumour in women under 40.
For patients with stage IB and IIA the primary treatment is surgery and for stages IIB, III and IV it is radiotherapy. The 5 year survival rate in IB and IIA patients is 85%. However, the clinical staging is not always correct (Nagell et al., 1971) . Pelvic lymph node metastases are found in 18-24% of these patients and 15-20% have tumour spread into the parametria (Ketting, 1981; Bleker et al., 1983) . In these cases additional radiotherapy is given, which means that the patients are then subjected to the risk of complications from both therapies. The size of the tumour and the depth of infiltration are important prognostic factors, but it is impossible to estimate them accurately pre-operatively (Burghardt et al., 1977 Table I ). Figure 1 shows the Ta patients without any sign of recurrence (see Table II ). There were 5 patients with a very high Ta-4 level (>35.0ngmV-1). Four of them were in stage IIB and 3 of these 4 died within 18 months of the primary treatment.
Our results, showing an increase in mean Ta-4 level with subsequent stages and higher values in patients with positive lymph nodes and/or recurrence of the disease, resemble those of Kato et al. (1982 Kato et al. ( ,1983 . In serial Ta-4 determinations after therapy they found a correlation between Ta-4 levels and response to therapy (1979). Maruo et al. (1985) found a decline of Ta-4 levels to normal within 72 h of radical surgery and within 3 months of radiotherapy. Based on these results they now give radiotherapy to those patients who do not show a decrease of Ta-4 levels after surgery. Patients who developed a recurrence showed a rise in Ta-4 levels in (Kato et al., 1984) . A remarkable feature of our data is that the highest Ta-4 levels were found in group IIB, especially in those patients suffering from a recurrence and who died within a few months after therapy. Ta-4 may therefore indicate the degree of activity of the tumour. The radioimmune assay method used in this study was not sensitive enough to detect sufficient amounts of in the early stages of cervical cancer. However, Suehiro et al. (1986) recently published the use of flow cytometric analysis of cervical smears with antiserum. With this combination they were able to detect 85% of squamous cervical carcinomas, with 20% false positive results. Patients with pre-cancerous lesions had abnormal histograms in 42% (CIN I and II) to 80% (CIN III). The cellular localization of Ta-4 was investigated by Ueda et al. (1986) by means of immunohistochemistry. could be detected in normal as well as in malignant cervical tissue.
Further development of a monoclonal antibody against squamous cell carcinoma of the cervix could provide an even more specific tumour marker.
The conclusion from the present data and the above mentioned literature is that Ta-4 could be a useful aid in the detection and determination of the extent of disease in patients with squamous cell cancer of the uterine cervix.
